ER–/PR+ breast cancer is controlled more effectively with an inflammatory inhibitor than hormonal inhibitor
Christine Song, A. Tuba Kendi, Ji Yeon Shim, Dawa Jung, Pil Soo Kang, Val J. Lowe, SeungBaek Lee
Topics & Concepts
Breast cancerTamoxifenMedicineEstrogen receptorHormonal therapyCancerCancer researchInternal medicineOncologyTriple-negative breast cancerBreast Cancer Treatment StudiesEstrogen and related hormone effectsCancer, Stress, Anesthesia, and Immune Response